Global Equine Drugs and Supplement market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get Access Now!

Global Equine Drugs and Supplement Market Growth Status and Outlook 2025-2031

The global Equine Drugs and Supplement market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Equine Drugs and Supplement Industry Forecast looks at past sales and reviews total world Equine Drugs and Supplement sales in 2024, providing a comprehensive analysis by region and market sector of projected Equine Drugs and Supplement sales for 2025 through 2031. With Equine Drugs and Supplement sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Drugs and Supplement industry. This Insight Report provides a comprehensive analysis of the global Equine Drugs and Supplement landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Drugs and Supplement portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Equine Drugs and Supplement market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Drugs and Supplement and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Drugs and Supplement. This report presents a comprehensive overview, market shares, and growth opportunities of Equine Drugs and Supplement market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Supplements &nbsp;&nbsp;&nbsp; Pharmaceutical Drugs Segmentation by Application: &nbsp;&nbsp;&nbsp; Drugstores &nbsp;&nbsp;&nbsp; Veterinary Hospitals &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Bayer Animal Health &nbsp;&nbsp;&nbsp; Boehringer Ingelheim &nbsp;&nbsp;&nbsp; Elanco (Eli Lilly) &nbsp;&nbsp;&nbsp; Merck Animal Health &nbsp;&nbsp;&nbsp; Merial &nbsp;&nbsp;&nbsp; Novartis Animal Health &nbsp;&nbsp;&nbsp; Zoetis Key Questions Addressed in this Report What is the 10-year outlook for the global Equine Drugs and Supplement market? What factors are driving Equine Drugs and Supplement market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Equine Drugs and Supplement market opportunities vary by end market size? How does Equine Drugs and Supplement break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Equine Drugs and Supplement Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Equine Drugs and Supplement by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Equine Drugs and Supplement by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Equine Drugs and Supplement Segment by Type &nbsp;2.2.1 Supplements &nbsp;2.2.2 Pharmaceutical Drugs &nbsp;2.3 Equine Drugs and Supplement Sales by Type &nbsp;2.3.1 Global Equine Drugs and Supplement Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Equine Drugs and Supplement Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Equine Drugs and Supplement Sale Price by Type (2020-2025) &nbsp;2.4 Equine Drugs and Supplement Segment by Application &nbsp;2.4.1 Drugstores &nbsp;2.4.2 Veterinary Hospitals &nbsp;2.4.3 Others &nbsp;2.5 Equine Drugs and Supplement Sales by Application &nbsp;2.5.1 Global Equine Drugs and Supplement Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Equine Drugs and Supplement Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Equine Drugs and Supplement Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Equine Drugs and Supplement Breakdown Data by Company &nbsp;3.1.1 Global Equine Drugs and Supplement Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Equine Drugs and Supplement Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Equine Drugs and Supplement Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Equine Drugs and Supplement Revenue by Company (2020-2025) &nbsp;3.2.2 Global Equine Drugs and Supplement Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Equine Drugs and Supplement Sale Price by Company &nbsp;3.4 Key Manufacturers Equine Drugs and Supplement Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Equine Drugs and Supplement Product Location Distribution &nbsp;3.4.2 Players Equine Drugs and Supplement Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Equine Drugs and Supplement by Geographic Region &nbsp;4.1 World Historic Equine Drugs and Supplement Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Equine Drugs and Supplement Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Equine Drugs and Supplement Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Equine Drugs and Supplement Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Equine Drugs and Supplement Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Equine Drugs and Supplement Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Equine Drugs and Supplement Sales Growth &nbsp;4.4 APAC Equine Drugs and Supplement Sales Growth &nbsp;4.5 Europe Equine Drugs and Supplement Sales Growth &nbsp;4.6 Middle East & Africa Equine Drugs and Supplement Sales Growth 5 Americas &nbsp;5.1 Americas Equine Drugs and Supplement Sales by Country &nbsp;5.1.1 Americas Equine Drugs and Supplement Sales by Country (2020-2025) &nbsp;5.1.2 Americas Equine Drugs and Supplement Revenue by Country (2020-2025) &nbsp;5.2 Americas Equine Drugs and Supplement Sales by Type (2020-2025) &nbsp;5.3 Americas Equine Drugs and Supplement Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Equine Drugs and Supplement Sales by Region &nbsp;6.1.1 APAC Equine Drugs and Supplement Sales by Region (2020-2025) &nbsp;6.1.2 APAC Equine Drugs and Supplement Revenue by Region (2020-2025) &nbsp;6.2 APAC Equine Drugs and Supplement Sales by Type (2020-2025) &nbsp;6.3 APAC Equine Drugs and Supplement Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Equine Drugs and Supplement by Country &nbsp;7.1.1 Europe Equine Drugs and Supplement Sales by Country (2020-2025) &nbsp;7.1.2 Europe Equine Drugs and Supplement Revenue by Country (2020-2025) &nbsp;7.2 Europe Equine Drugs and Supplement Sales by Type (2020-2025) &nbsp;7.3 Europe Equine Drugs and Supplement Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Equine Drugs and Supplement by Country &nbsp;8.1.1 Middle East & Africa Equine Drugs and Supplement Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Equine Drugs and Supplement Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Equine Drugs and Supplement Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Equine Drugs and Supplement Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Equine Drugs and Supplement &nbsp;10.3 Manufacturing Process Analysis of Equine Drugs and Supplement &nbsp;10.4 Industry Chain Structure of Equine Drugs and Supplement 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Equine Drugs and Supplement Distributors &nbsp;11.3 Equine Drugs and Supplement Customer 12 World Forecast Review for Equine Drugs and Supplement by Geographic Region &nbsp;12.1 Global Equine Drugs and Supplement Market Size Forecast by Region &nbsp;12.1.1 Global Equine Drugs and Supplement Forecast by Region (2026-2031) &nbsp;12.1.2 Global Equine Drugs and Supplement Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Equine Drugs and Supplement Forecast by Type (2026-2031) &nbsp;12.7 Global Equine Drugs and Supplement Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Bayer Animal Health &nbsp;13.1.1 Bayer Animal Health Company Information &nbsp;13.1.2 Bayer Animal Health Equine Drugs and Supplement Product Portfolios and Specifications &nbsp;13.1.3 Bayer Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Bayer Animal Health Main Business Overview &nbsp;13.1.5 Bayer Animal Health Latest Developments &nbsp;13.2 Boehringer Ingelheim &nbsp;13.2.1 Boehringer Ingelheim Company Information &nbsp;13.2.2 Boehringer Ingelheim Equine Drugs and Supplement Product Portfolios and Specifications &nbsp;13.2.3 Boehringer Ingelheim Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Boehringer Ingelheim Main Business Overview &nbsp;13.2.5 Boehringer Ingelheim Latest Developments &nbsp;13.3 Elanco (Eli Lilly) &nbsp;13.3.1 Elanco (Eli Lilly) Company Information &nbsp;13.3.2 Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolios and Specifications &nbsp;13.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Elanco (Eli Lilly) Main Business Overview &nbsp;13.3.5 Elanco (Eli Lilly) Latest Developments &nbsp;13.4 Merck Animal Health &nbsp;13.4.1 Merck Animal Health Company Information &nbsp;13.4.2 Merck Animal Health Equine Drugs and Supplement Product Portfolios and Specifications &nbsp;13.4.3 Merck Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Merck Animal Health Main Business Overview &nbsp;13.4.5 Merck Animal Health Latest Developments &nbsp;13.5 Merial &nbsp;13.5.1 Merial Company Information &nbsp;13.5.2 Merial Equine Drugs and Supplement Product Portfolios and Specifications &nbsp;13.5.3 Merial Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Merial Main Business Overview &nbsp;13.5.5 Merial Latest Developments &nbsp;13.6 Novartis Animal Health &nbsp;13.6.1 Novartis Animal Health Company Information &nbsp;13.6.2 Novartis Animal Health Equine Drugs and Supplement Product Portfolios and Specifications &nbsp;13.6.3 Novartis Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Novartis Animal Health Main Business Overview &nbsp;13.6.5 Novartis Animal Health Latest Developments &nbsp;13.7 Zoetis &nbsp;13.7.1 Zoetis Company Information &nbsp;13.7.2 Zoetis Equine Drugs and Supplement Product Portfolios and Specifications &nbsp;13.7.3 Zoetis Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Zoetis Main Business Overview &nbsp;13.7.5 Zoetis Latest Developments 14 Research Findings and Conclusion

Report	Global Equine Drugs and Supplement Market Growth 2025-2031
Selected License	Multi ID: LPI35512

Buyer Information

Order Summary